Results for tag: "Gamma Glutamyl Transferase"

The Gamma Glutamyl Transferase (GGT) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. GGT is an enzyme found in the liver and is used to detect liver damage, as well as to diagnose and monitor liver diseases. GGT is also used to detect bile duct obstruction, alcohol abuse, and certain types of cancer. The increasing prevalence of liver diseases, rising awareness of early diagnosis, and technological advancements in IVD are driving the growth of the GGT market. The GGT market is segmented by product type, end user, and region. Product type includes reagents and kits, instruments, and software and services. End users include hospitals, diagnostic laboratories, and research laboratories. Regionally, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Some of the key players in the GGT market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Ortho Clinical Diagnostics, Sysmex Corporation, bioMérieux SA, Randox Laboratories Ltd., Diazyme Laboratories, and Thermo Fisher Scientific. Show Less Read more